Lazorthes Y, Richaud J, Roger B, Lagarrigue J, Verdie J C, Bonafe A
Neurochirurgie. 1985;31(6):471-93.
Enzymatic dissolution of nucleus pulposus by percutaneous injection of a papain preparation is now used frequently to treat lumbosacral disc hernias responsible for resistant sciatica. Mechanisms of action and techniques are reviewed, and the importance of applying strict criteria for indications for use emphasized. The method should be reserved for nerve root sciatica resistant to medical treatment or physiotherapy, and it constitutes the last stage of conservative treatment. Exclusion criteria are mainly "excluded" disc lesions, major dysfunction or associated spinal vertebral canal stenosis. The optimal indication is represented by the subacute disc hernia in the young. This alternative to open surgery in no way compromises the results in case of failure. Results obtained in a personal series of 150 cases are analyzed comparatively with those reported in the literature.
经皮注射木瓜蛋白酶制剂对髓核进行酶解,目前常用于治疗导致顽固性坐骨神经痛的腰骶椎间盘突出症。本文综述了其作用机制和技术,并强调了应用严格使用指征标准的重要性。该方法应仅用于对药物治疗或物理治疗无效的神经根型坐骨神经痛,且它是保守治疗的最后阶段。排除标准主要是“排除在外”的椎间盘病变、严重功能障碍或相关的脊椎椎管狭窄。最佳适应证是年轻人的亚急性椎间盘突出症。这种开放手术的替代方法在失败的情况下绝不会影响治疗效果。将本人一组150例病例的结果与文献报道的结果进行了比较分析。